Leaflet NACRALID 2.5mg film-coated tablets


Indicated for: migraine

Route of administration: oral

Substance: naratriptan (serotonin agonist antimigraine)

ATC: N02CC02 (Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists)

Naratriptanum is a medication used for the treatment of acute migraine, with or without aura. It belongs to the class of serotonin receptor agonists (triptans) and works by constricting dilated blood vessels in the brain, reducing pain and other migraine-associated symptoms.

The medication is taken orally, usually in tablet form, and is effective in providing rapid relief from migraine symptoms. It is intended for occasional use and should not be used for migraine prevention.

Side effects may include nausea, dizziness, fatigue, or a sensation of pressure in the chest. In rare cases, severe reactions such as high blood pressure or cardiac ischemia may occur.

Consult your doctor before use, especially if you have cardiovascular conditions or are taking other medications. Use Naratriptanum as directed to avoid complications.

General data about NACRALID 2.5mg

  • Substance: naratriptan
  • Date of last drug list: 01-07-2013
  • Commercial code: W56577003
  • Concentration: 2.5mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 3
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: CENTRAFARM SERVICES BV - OLANDA
  • Holder: STADA HEMOFARM S.R.L. - ROMANIA
  • Number: 7933/2015/03
  • Shelf life: 4 years